Correlation of Time to Treatment with Attack Duration in the Sebetralstat KONFIDENT Phase 3 TrialCraig TJ, Bernstein JA, Longhurst H, Hao J, Smith MD, Audhya PK, Yea CM, Maurer M
ACAAI 2024
On-demand Treatment of Laryngeal Hereditary Angioedema Attacks with Sebetralstat: Pooled Analysis from KONFIDENT and KONFIDENT-SAygören-Pürsün E, Bernstein JA, Lumry WR, Audhya PK, Hao J, Smith MD, Yea CM, Riedl MA
ACAAI 2024
Indirect treatment comparison of oral sebetralstat and intravenous rhC1-INH as on-demand treatments for hereditary angioedemaLi HH, Mager M, Craig TJ, Manning ME, Hummel N, Wang A, Audhya PK, Bernstein JA
ACAAI 2024
Phase 3 KONFIDENT Trial of Oral Sebetralstat for Treatment of Hereditary Angioedema Attacks: Analysis of the European and US Patient SubgroupsZanichelli A, Aygören-Pürsün E, Bernstein JA, Farkas H, Lumry WR, Maurer M, Riedl MA, Hao J, Smith MD, Audhya PK, Yea C, Cohn DM
ACARE Global Angioedema Forum 2024 (GAF)
Impact of Oral Sebetralstat on Anxiety Associated with Hereditary Angioedema Attacks in the Phase 3 KONFIDENT TrialMaurer M, Cohn DM, Bernstein JA, Farkas H, Lumry WR, Riedl MA, Zanichelli A, Hao J, Smith MD, PK Audhya, Yea CM, Aygören-Pürsün E
ACARE Global Angioedema Forum 2024 (GAF)
Pooled Sebetralstat Placebo-controlled Safety for On-demand Treatment of Hereditary Angioedema (Oral Presentation)Aygören-Pürsün E
Bradykinin Symposium 2024
Pooled Sebetralstat Placebo-controlled Efficacy for On-demand Treatment of Hereditary Angioedema (Poster Presentation)Aygören-Pürsün E
Bradykinin Symposium 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksRiedl MA, Farkas H, Aygören-Pürsün E, Psarros F, Soteres DF, M.D., Staevska M, Cancian M
New England Journal of Medicine
Sebetralstat: A Rapidly Acting Oral Plasma Kallikrein Inhibitor for the On-Demand Treatment of Hereditary AngioedemaFeener EP, Davie RL, Murugesan N, Pethen SJ, Hampton SL, Smith MD, Audhya PK, Yea CM
Drugs and Drug Candidates
Evaluation of patient‐reported outcome measures for on‐demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of sebetralstatCohn DM, Aygören-Pürsün E, Bernstein JA, Farkas H, Lumry WR, Maurer M, Zanichelli A, Iverson M, Hao J, Smith MD, Yea CM, Audhya PK, Riedl MA
Clinical Translation Allergy